These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17143974)

  • 1. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies in normals--the value of predicting rheumatoid arthritis.
    Dörner T; Hansen A
    Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic.
    Madan A; Belshaw R; Grennan D
    QJM; 2007 Nov; 100(11):737-8. PubMed ID: 17951317
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 7. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 10. Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?
    Symmons DP
    Rheumatology (Oxford); 2007 May; 46(5):725-6. PubMed ID: 17215261
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
    Jansen TL; Bruyn GA
    J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis].
    Ota T
    Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L; Uddhammar A; Rantapää-Dahlqvist S
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
    Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?
    Gao IK; Haas-Wöhrle A; Mueller KG; Lorenz HM; Fiehn C
    Ann Rheum Dis; 2005 Oct; 64(10):1516-7. PubMed ID: 16162906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.